{
  "labels": {
    "done": "已完成",
    "current": "当前",
    "planned": "计划中",
    "tentative": "待定",

    "diagnosis": "诊断",
    "chemotherapy": "化疗",
    "radiotherapy": "放疗",
    "transplant": "移植",
    "rehab": "康复",
    "event": "事件",
    "other": "其他"
  },
  "ui": {
    "page_title": "医疗时间线",
    "meta_updated": "更新于",
    "legend_done": "Done — 已完成的阶段/事件",
    "legend_now": "Now — 当前阶段",
    "legend_planned": "Planned — 计划/预期",
    "legend_tentative": "Tentative — 可能，未确认",
    "section_completed": "已完成",
    "section_now": "当前",
    "section_plans": "计划",
    "no_entries": "暂无条目。",
    "btn_details": "详情",
    "btn_hide": "收起",
    "confidence": "置信度",
    "notice_tbd": "“TBD” = “待确定”。本路线图仅供参考，不构成医疗建议。"
  },
  "items": {
    "2019-01-dx-staging": {
      "when_label": "2019年1–3月",
      "title": "初始诊断——T淋巴母细胞淋巴瘤；分期",
      "summary": "基线检查确认T淋巴母细胞淋巴瘤；完成分期与基线评估。",
      "details": "血液科会诊、影像与活检明确诊断与分期。开始治疗前记录心功能与化验基线。"
    },
    "2019-03-first-chemo-rt": {
      "when_label": "2019年3–8月",
      "title": "T淋巴母细胞淋巴瘤化疗",
      "summary": "系统化疗与支持治疗；辅助放疗。",
      "details": "按计划分期评估疗效并结疗评估。放疗用于巩固（约30次）。"
    },
    "2020-04-relapse-dx": {
      "when_label": "2020年4月",
      "title": "复发——T淋巴母细胞淋巴瘤（确诊）",
      "summary": "确证复发；更新治疗方案。",
      "details": "诊断复核再次确认T‑LBL；建议重启系统治疗。"
    },
    "2020-04-11-chemo-rt-mi": {
      "when_label": "2020年4–11月",
      "title": "化疗 + 放疗×30；严重消化道出血与心肌梗死",
      "summary": "恢复化疗与放疗；消化性溃疡出血导致心梗；稳定后继续治疗。",
      "details": "重度贫血与心律失常以输血与重症监护处理。放疗与化疗并行（约30次）。"
    },
    "2021-05-aggressive-leukocytosis-dx": {
      "when_label": "2021年5月",
      "title": "侵袭性白血病伴极度白细胞增多——诊断",
      "summary": "白细胞 >30万；确诊；启动细胞减灭治疗。",
      "details": "病程进展迅速（后示Ph+特征）；需紧急细胞减灭与输血支持。"
    },
    "2021-05-2023-09-chemo-aggr-leukemia": {
      "when_label": "2021年5月–2023年9月",
      "title": "针对侵袭性白血病的化疗",
      "summary": "长期系统治疗，以达到CAR‑T准入并控制病情。",
      "details": "递增/个体化方案以降低白细胞至CAR‑T阈值以下；合并感染随治随管。"
    },
    "2022-03-26-neuro-shock": {
      "when_label": "2022年3–4月",
      "title": "全身性休克并瘫痪与失忆",
      "summary": "需复苏；继发神经功能缺损，后逐步恢复。",
      "details": "急性崩溃行复苏。随后：瘫痪、运动性失语/失忆、认知减慢；在神经科随访下阶梯式恢复。"
    },
    "2022-10-invasive-fungal-sepsis": {
      "when_label": "2022年10月",
      "title": "侵袭性真菌感染并脓毒症",
      "summary": "严重口咽部病灶并全身受累；治疗成功。",
      "details": "住院抗感染治疗；并见心律失常与2022年微卒中样症状。"
    },
    "2022-12-covid-icu-gi-bleed": {
      "when_label": "2022年12月–2023年1月",
      "title": "新冠肺炎（ICU、插管）与消化道出血；恢复",
      "summary": "免疫抑制背景下病情危重并需插管与昏迷；随后稳定。",
      "details": "免疫抑制中肺炎快速恶化 → ICU、插管与昏迷；ICU后康复，逐步稳定。"
    },
    "2023-06-respiratory-arrest-sepsis": {
      "when_label": "2023年6–9月",
      "title": "呼吸骤停（复苏）与菌血症；强化化疗",
      "summary": "事件控制；罕见菌血症治愈；为达CAR‑T阈值强化化疗。",
      "details": "强化治疗以将白细胞降至CAR‑T阈值以下；并发感染随治。"
    },
    "2023-10-car-t": {
      "when_label": "2023年10–11月",
      "title": "CAR‑T治疗",
      "summary": "实施CAR‑T；严重毒性（发热、神经及心脏事件）得到控制。",
      "details": "高热、呕吐、下肢短暂瘫痪…… 符合神经毒性表现；随后逐步恢复。"
    },
    "2024-01-allo-sct-brother-bradonor": {
      "when_label": "2024年1月",
      "title": "同种异体造血干细胞输注——兄弟供者",
      "summary": "CAR‑T后以同种干细胞作巩固。",
      "details": "植入期严格感染控制；随后门诊恢复。"
    },
    "2024-07-abdominal-mass-hl": {
      "when_label": "2024年7月",
      "title": "巨大腹部肿块；侵袭性霍奇金淋巴瘤",
      "summary": "新发HL，与既往不同；治疗策略调整。",
      "details": "可能与既往治疗相关…… 肿瘤科提出新的化疗策略。"
    },
    "2024-08-2025-06-chemo-rt": {
      "when_label": "2024年8月–2025年6月",
      "title": "强化化疗 → 败血症 → 改为有效方案；放疗×30",
      "summary": "初始大剂量致败血症；改用更耐受且有效的方案；加做放疗（30次）。",
      "details": "败血症后调整方案以兼顾疗效与耐受性。放疗作为巩固（30个工作日）。"
    },
    "2025-06-relapse-Ph-pos": {
      "when_label": "2025年6月下旬",
      "title": "白细胞上升；发现Ph+淋巴系细胞",
      "summary": "白细胞数数日内由约3.5万升至约6.7万；证实Ph+淋巴系。",
      "details": "肿瘤科建议口服化疗，稳定后转入TKI（泊纳替尼）。"
    },
    "2025-07-oral-chemo-14": {
      "when_label": "2025年7月–现在",
      "title": "口服多药化疗（14剂）",
      "summary": "在家进行的结构化口服方案，共14剂。",
      "details": "复杂口服组合，中期监测实验室与耐受；疗程结束后做决策评估。"
    },
    "plan-2025-support-recovery": {
      "when_label": "化疗后（待定）",
      "title": "支持与功能恢复",
      "summary": "结构化支持治疗与康复。",
      "details": "具体强度与节奏将依据化疗后状态与化验趋势调整。"
    },
    "plan-2025-tki-lifelong": {
      "when_label": "稳定后（待定）",
      "title": "酪氨酸激酶抑制剂（泊纳替尼）——长期",
      "summary": "细胞减灭后维持性TKI；可能长期/终身。",
      "details": "在血液学控制可接受后启动；监测疗效与不良反应；预计需剂量调整。"
    },
    "plan-2025-re-irradiation": {
      "when_label": "如指征（待定）",
      "title": "可能的再次放疗",
      "summary": "如需局部控制，可考虑。",
      "details": "肿瘤多学科讨论决定；依赖影像与既往放疗剂量。"
    },
    "plan-2025-chemo-switch": {
      "when_label": "如当前方案不足（待定）",
      "title": "可能更换当前化疗方案",
      "summary": "若疗效不足或毒性不可接受，则更换。",
      "details": "复评化验/影像与耐受后决定；必要时改选替代方案。"
    },
    "plan-2025-next-line-chemo": {
      "when_label": "如需要（待定）",
      "title": "可能的后续化疗线",
      "summary": "根据病情进展决定的备选方案。",
      "details": "由肿瘤会诊在评估当前疗程后决定。"
    },
    "plan-2026-repeat-allo-sct": {
      "when_label": "2026年（可能）",
      "title": "可能再次行同种异体移植",
      "summary": "如需最终巩固，可考虑此选项。",
      "details": "取决于对TKI与化疗的反应；需评估供者/中心并权衡风险与获益。"
    }
  }
}
